CAG Stock Analysis: Conagra Brands | NYSE
Packaged Foods | NYSE, USA | Market Cap: 7.097m USD | 12M Return: -13.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 250M
EPS Trend: -96.5%
Qual. Beats: 0
Rev. Trend: -97.7%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Conagra Brands (NYSE: CAG) is a U.S.-focused consumer packaged goods (CPG) food company headquartered in Chicago, Illinois, operating through four reportable segments: Grocery & Snacks (shelf-stable foods), Refrigerated & Frozen (temperature-controlled foods), International (retail and foodservice outside the U.S.), and Foodservice (branded and customized products sold to restaurants and other foodservice operators). The company markets a portfolio of well-known brands including Birds Eye, Marie Callenders, Duncan Hines, Healthy Choice, Slim Jim, Reddi-wip, Angies, and BOOMCHICKAPOP, distributed primarily through U.S. retail channels with a smaller international and foodservice presence. Conagra was incorporated in 1919 and trades as a mid-cap stock in the Consumer Staples sector (Packaged Foods & Meats sub-industry).
As a packaged food manufacturer, Conagras business model depends on brand equity, broad distribution across grocery retailers, and the ability to pass input cost volatility (e.g., commodities, packaging, logistics) through to consumers. The Foodservice segment adds a separate demand driver tied to restaurant traffic and away-from-home eating, which historically behaves differently from at-home retail consumption.
- Frozen and snacks portfolio drives organic sales growth
- Input cost inflation pressures packaged food gross margins
- Private label competition compresses branded grocery volumes
- Foodservice segment rebounds on restaurant traffic recovery
| Net Income: -1.92b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -0.56 > 1.0 |
| NWC/Revenue: -2.71% < 20% (prev -10.73%; Δ 8.02% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.40b > Net Income -1.92b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.90 > 1.5 & < 3 |
| Outstanding Shares: last quarter (479.0m) vs 12m ago 0.17% < -2% |
| Gross Margin: 23.92% > 18% (prev 25.86%; Δ -1.95% > 0.5%) |
| Asset Turnover: 59.05% > 50% (prev 55.47%; Δ 3.58% > 0%) |
| Interest Coverage Ratio: -4.26 > 6 (EBIT TTM -1.63b / Interest Expense TTM 382.6m) |
| A: -0.02 (Total Current Assets 2.88b - Total Current Liabilities 3.19b) / Total Assets 17.3b |
| B: 0.24 (Retained Earnings 4.17b / Total Assets 17.3b) |
| C: -0.09 (EBIT TTM -1.63b / Avg Total Assets 19.1b) |
| D: 0.58 (Book Value of Equity 6.36b / Total Liabilities 10.9b) |
| Altman-Z'' = 0.71 = B |
| DSRI: 0.88 (Receivables 658.2m/770.0m, Revenue 11.3b/11.6b) |
| GMI: 1.08 (GM 25.86% / 23.92%) |
| AQI: 0.93 (AQ_t 0.67 / AQ_t-1 0.72) |
| SGI: 0.97 (Revenue 11.3b / 11.6b) |
| TATA: -0.19 (NI -1.92b - CFO 1.40b) / TA 17.3b) |
| Beneish M = -3.13 (Cap -4..+1) = AA |
As of July 28, 2026, the stock is trading at USD 15.24 with a total of 12,582,434 shares traded. Over the past week, the price has changed by +4.10%, over one month by +9.01%, over three months by +10.65% and over the past year by -13.76%.
Current recommended Stop Loss: 14.30 (which is 6.2% or 1.7 ATR below the current price).
Conagra Brands has received a consensus analysts rating of 3.16. Therefore, it is recommended to hold CAG.
- StrongBuy: 0
- Buy: 3
- Hold: 16
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 14.4 | -5.6% |
P/E Forward = 9.9108
P/S = 0.6101
P/B = 1.0817
P/EG = 12.0743
Revenue TTM = 11.3b USD
EBIT TTM = -1.63b USD
EBITDA TTM = -1.23b USD
Long Term Debt = 6.46b USD (from longTermDebt, last quarter)
Short Term Debt = 812.4m USD (from shortTermDebt, last quarter)
Debt = 7.44b USD (from shortLongTermDebtTotal, last quarter) + Leases 172.2m
Net Debt = 7.22b USD (calculated: Debt 7.44b - CCE 218.0m)
Enterprise Value = 14.3b USD (7.10b + Debt 7.44b - CCE 218.0m)
Interest Coverage Ratio = -4.26 (Ebit TTM -1.63b / Interest Expense TTM 382.6m)
EV/FCF = 14.63x (Enterprise Value 14.3b / FCF TTM 978.7m)
FCF Yield = 6.83% (FCF TTM 978.7m / Enterprise Value 14.3b)
FCF Margin = 8.68% (FCF TTM 978.7m / Revenue TTM 11.3b)
Net Margin = -16.99% (Net Income TTM -1.92b / Revenue TTM 11.3b)
Gross Margin = 23.92% ((Revenue TTM 11.3b - Cost of Revenue TTM 8.58b) / Revenue TTM)
Gross Margin QoQ = 24.35% (prev 23.59%)
Tobins Q-Ratio = 0.83 (Enterprise Value 14.3b / Total Assets 17.3b)
Interest Expense / Debt = 5.14% (Interest Expense 382.6m / Debt 7.44b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -1.29b (EBIT -1.63b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.90 (Total Current Assets 2.88b / Total Current Liabilities 3.19b)
Debt / Equity = 1.17 (Debt 7.44b / totalStockholderEquity, last quarter 6.36b)
Debt / EBITDA = -5.86 (negative EBITDA) (Net Debt 7.22b / EBITDA -1.23b)
Debt / FCF = 7.38 (Net Debt 7.22b / FCF TTM 978.7m)
Total Stockholder Equity = 7.88b (last 4 quarters mean from totalStockholderEquity)
RoA = -10.03% (Net Income -1.92b / Total Assets 17.3b)
RoE = -24.31% (Net Income TTM -1.92b / Total Stockholder Equity 7.88b)
RoCE = -11.36% (EBIT -1.63b / Capital Employed (Equity 7.88b + L.T.Debt 6.46b))
RoIC = -8.76% (negative operating profit) (NOPAT -1.29b / Invested Capital 14.7b)
WACC = 4.69% (E(7.10b)/V(14.5b) * Re(5.34%) + D(7.44b)/V(14.5b) * Rd(5.14%) * (1-Tc(0.21)))
Discount Rate = 5.34% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -35.53 | Cagr: -0.09%
[DCF] Terminal Value 73.10% ; FCFF base≈1.11b ; Y1≈971.9m ; Y5≈785.2m
[DCF] Fair Price = 11.24 (EV 12.6b - Net Debt 7.22b = Equity 5.38b / Shares 478.6m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -96.50 | EPS CAGR: -17.03% | SUE: 0.24 | # QB: 0
Revenue Correlation: -97.73 | Revenue CAGR: -3.54% | SUE: 0.12 | # QB: 0
EPS current Quarter (2026-08-31): EPS=0.28 | Chg30d=-23.82% | Revisions=-73% | Analysts=14
EPS next Quarter (2026-11-30): EPS=0.41 | Chg30d=-4.27% | Revisions=-75% | Analysts=13
EPS current Year (2027-05-31): EPS=1.45 | Chg30d=-8.71% | Revisions=-79% | GrowthEPS=-15.9% | GrowthRev=-3.9%
EPS next Year (2028-05-31): EPS=1.57 | Chg30d=-5.47% | Revisions=-73% | GrowthEPS=+8.7% | GrowthRev=+0.9%
[Analyst] Revisions Ratio: -92% (up=0, down=36)